Curaleaf Holdings (CURLF) Total Non-Current Liabilities (2019 - 2025)

Curaleaf Holdings (CURLF) recorded quarterly Total Non-Current Liabilities of $1.3 billion in Q4 2025, up 1.85% quarter-over-quarter from $1.3 billion in Q4 2024, and up 1.85% on a YoY basis from $1.3 billion in Q4 2024.

Curaleaf Holdings (CURLF) Total Non-Current Liabilities (2019 - 2025) Analysis & Trends

Curaleaf Holdings' Total Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $1.3 billion for Q4 2025.

  • In Q4 2025, Total Non-Current Liabilities rose 1.85% year-over-year to $1.3 billion; the TTM figure through Dec 2025 stood at $1.3 billion (up 1.85% YoY), while the FY2025 annual figure was $1.3 billion, up 1.85% from the prior year.
  • Total Non-Current Liabilities was $1.3 billion for Q4 2025 at Curaleaf Holdings, up from $1.3 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $2.0 billion in Q3 2023 to a low of -$6.6 billion in Q1 2022.
  • Historically, Total Non-Current Liabilities has averaged $866.1 million across 5 years, with a median of $1.4 billion in 2023.
  • Biggest YoY gain for Total Non-Current Liabilities was 23719.32% in 2022; the steepest drop was 716.6% in 2022.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $4.2 million in 2021, then jumped by 23719.32% to $1.0 billion in 2022, then soared by 33.87% to $1.4 billion in 2023, then fell by 4.82% to $1.3 billion in 2024, then grew by 1.85% to $1.3 billion in 2025.
  • The last three Total Non-Current Liabilities figures came in at $1.3 billion (Q4 2025), $1.3 billion (Q4 2024), and $1.6 billion (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 18.28 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 11.64 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 599.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 44.12 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 1.24 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 6.26 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 2.44 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1.13 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 1.81 Bn
10 Curaleaf Holdings - - 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.31 Bn
Dec 31, 2024 1.29 Bn
Sep 30, 2024 1.61 Bn
Jun 30, 2024 1.64 Bn
Dec 31, 2023 1.35 Bn
Sep 30, 2023 2.01 Bn
Jun 30, 2023 1.99 Bn
Dec 31, 2022 1.01 Bn
Sep 30, 2022 1.83 Bn
Jun 30, 2022 1.73 Bn
Mar 31, 2022 -6.61 Bn
Dec 31, 2021 4.24 Mn
Sep 30, 2021 1.41 Bn
Jun 30, 2021 1.34 Bn
Mar 31, 2021 1.07 Bn
Dec 31, 2020 982.82 Mn
Sep 30, 2020 973.34 Mn
Dec 31, 2019 300.86 Mn